Positive response to galcanezumab following treatment failure to onabotulinumtoxinA in patients with migraine: <i>post hoc</i> analyses of three randomized double‐blind studiesJessica Ailani, Sheena K. Aurora, Eric Pearlman et al.|European Journal of Neurology|2019Cited by 26